Skip to content
Medx

Tag: Sapropterin

Explore our medication guides and pharmacology articles within this category.

Understanding the Role: Is KUVAN an Enzyme Replacement Therapy?

•
4 min read
According to the FDA, Kuvan (sapropterin dihydrochloride) was approved in 2007 as a treatment for certain types of Phenylketonuria (PKU). So, is KUVAN an enzyme replacement therapy? The answer requires a closer look at its unique pharmacological function as a cofactor, not an enzyme replacement.

What is kuvan for? Understanding a Key Medication for PKU Management

•
5 min read
Approved by the FDA in 2007, Kuvan (sapropterin dihydrochloride) is a prescription medication used to address the genetic disorder phenylketonuria (PKU). This treatment specifically targets patients with BH4-responsive PKU, lowering their blood phenylalanine levels in conjunction with a restricted diet.